Infection Flashcards

1
Q

B lactam classes

A

Penicillins, Cephalosporins, Carbapenems, Monobactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bactericidal vs bacteriostatic

A

Bactericidal: kills (usually by inhibiting cell wall synthesis), bacteriostatic: inhibits reproduction/growth (inhibits protein synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Penicillin MOA

A

Bind to Penicillin binding protein (PBP), reduces peptidoglycan layer, bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Penicillin resistance causes

A

B-lactamases and PBP mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cephalosporin MOA

A

Bind to Penicillin binding protein (PBP), reduces peptidoglycan layer, bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cephalosporin resistance causes

A

B-lactamases and PBP mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Carbapenems MOA

A

Bind to Penicillin binding protein (PBP), reduces peptidoglycan layer, bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Carbapenem resistance causes

A

B lactamases only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Monobactams MOA

A

Bind to Penicillin binding protein (PBP), reduces peptidoglycan layer, bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Monobactam resistance causes

A

B lactamases, less susceptible than other B lactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aminoglycoside drugs

A

Gentamicin, amikacin, neomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aminoglycoside spectrum of activity

A

gram negative aerobes (and some activity against staph and mycobacteria) No activity against anaerobes of streptococci as aminoglycosides require oxygen dependant transport into cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aminoglycoside MOA

A

Bind irreversibly to bacterial ribosomes (30s), inhibiting protein sysnthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aminoglycoside resistance causes

A

Reduced cell wall permeability, enzymatic alteration of aminoglycoside

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aminoglycoside ADRs

A

Nephrotoxicity and Ototoxicity (accumulate in renal tubular epithelial cells and cochlear/vestibular hair cells, causing cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aminoglycoside warnings

A

neonates, elderly, renal impairment, myasthenia gravis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aminoglycoside interactions

A

Loop diuretics (inc risk of ototoxicity), Nephrotoxicity risk increased with ciclosporin, platinum chemotherapy, cephalosporins or vancomycin.

18
Q

Gentamicin dosing

A

Based on IBW as only distrubutes in body water and not body fat

19
Q

Nystatin MOA

A

Bind to ergosterol in fungal cells, creates a polar pore, allows ion leakage.

20
Q

Imidazole antifungals

A

clotrimazole

21
Q

Triazole antifungals

A

fluconazole

22
Q

Imidazole and triazole MOA

A

Inhibit ergosterol synthesis, which impairs cell membrane synthesis

23
Q

Antifungal resistance

A

Rare, can occur in long term use in immunocompromised patients. Mechanisms include alteration of membrane synthesis to exclude ergosterol

24
Q

Antifungal ADRs

A

Local use - irritation
PO Fluconazole - GI upset, headache, hepatitis and hypersensitivity. Rare- severe hepatic toxicity, QT- prolongation, anaphylaxis

25
Q

Antifungal warnings

A

Topical- none

Fluconazole, liver damage, moderate renal impairment (dose reduction required).

26
Q

Antifungal Contraindications

A

Pregnancy

27
Q

Antifungal interactions

A

No significant interactions for topicals.
Fluconazole inhibits CYP450, so drugs metabolised by CYP450 including carbamazepine, phenytoin, warfarin, diazepam, simvastatin, sulphonylureas. Causes QT prolongation, so other drugs that cause QT prolongation (amiodarone, antipsychotics, quinine, quinolone, macrolides and SSRIs

28
Q

Aciclovir MOA

A

Inhibits the herpes specific DNA polymerase

29
Q

Aciclovir ADRs

A

headache, dizziness, GI disturbances, rash.

IV use: phlebitis, acute renal failure (risk reduced by slow rate and adequate hydration)

30
Q

Aciclovir warnings

A

Crosses placenta and enters breast milk, so caution in pregnancy and breastfeeding. Severe renal impairment. No CIs

31
Q

Aciclovir interactions

A

None of note

32
Q

Cephalosporins and Carbapenams spectrum of activity

A

Broad

33
Q

Antibiotics increasing C diff risk the most

A

clindamycin, cephalosporins (in particular second‑ and third‑generation cephalosporins), quinolones, co‑amoxiclav and aminopenicillins (for example, ampicillin and amoxicillin, which may be related to their volume of use rather than being ‘high risk’)

34
Q

Carbapenems warnings

A

Epilsepsy (lowers seizure threshold). CI in anaphylaxis to B lactams.

35
Q

Carbapenem and cephalosporin interactions

A

Warfarin: increases INR by killing gut bacteria that produce vitamin K.
May increase aminoglycoside nephrotoxicity

36
Q

Chloramphenicol uses

A

Bacterial conjunctivitis, otitis externa. Occasional use Po or IV, but only in very exceptional and life threatening situations.

37
Q

Chloramphenicol activity

A

Broad against gram pos and neg, aerobes and anaerobes.

38
Q

Chloraphenicol MOA

A

Binds to bacterial ribosomes, inhibits protein synthesis (bacteriostatic).

39
Q

Chloramphenicol resistance

A

acetyltransferase enzymes that directly inactivate the drug. Target modification, decreased membrane permeability and increased efflux pumps

40
Q

Chloramphenicol ADRs

A

Topical: stinging, burning, itching.
Systemic: Bone marrow toxicity - 1. dose related (more common in high doses or in accumulation due to hepatic impairment) occurs on treatment and reversed on withdrawal. 2. Aplastic anaemia - idiosynchratic, unpredictable, may occur a while after starting. Rare but life threatening.
Gray baby syndrome- circulatory collapse in exposed neonates. Optic and peripheral neuritis may occur with prolonged use

41
Q

Chloramphenicol warnings

A

CI: hypersensitivity reactions, bone marrow disorders, systemic CIs include third trimester, breastfeeding and children under 2. Topical use should also be avoided where possible.
Hepatic impairment

42
Q

OTC chlorpamphenicol red flags

A

Loss of/disturbance of vision, contact lenses use, photophobia, unresolved after using drops.